(Reuters) - Allergan Inc shareholder Paulson & Co is urging the Botox maker to merge with speciality pharmaceutical company Shire Plc as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc , according to two people familiar with the matter.